Report of Foreign Issuer (6-k)
February 21 2017 - 7:02AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For
the month of February 2017
Commission
File Number 001-37381
MEDIGUS
LTD.
(Translation of registrant’s name into English)
Omer
Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
EXPLANATORY
NOTE
Medigus
Ltd., or the Company, hereby furnishes the following documents:
|
(i)
|
Notice
and Proxy Statement with respect to the Company’s extraordinary general meeting of the shareholders to be held on March
20, 2017, describing the proposals to be voted upon at the meeting, the procedure for voting in person or by proxy at the
meeting and various other details related to the meeting; and
|
|
(ii)
|
A
Proxy Card whereby holders of American depository shares, evidenced by American depositary receipts, of the Company may vote
at the meeting without attending in person.
|
The
Notice and Proxy Statement is furnished with this Form 6-K as Exhibit 99.1 and the Proxy Card is furnished with this Form 6-K
as Exhibit 99.2
.
This Form 6-K
is incorporated by reference into the Company’s Registration Statement on Form F-3 filed with the Securities and Exchange
Commission on August 24, 2016 (Registration No. 333- 213280) and its Registration Statement on Form S-8 filed with the Securities
and Exchange Commission on September 9, 2015 (Registration No. 333-206803).
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
MEDIGUS
LTD.
|
|
|
|
Date:
February 21, 2017
|
By:
|
/s/
Oded Yatzkan
|
|
|
Oded
Yatzkan
|
|
|
Chief
Financial Officer
|
EXHIBIT
INDEX
Exhibit
|
|
Description
|
|
|
|
99.1
|
|
Notice
and Proxy Statement for the Extraordinary General Meeting of Shareholders of the Company to be held on March 20, 2017.
|
|
|
|
99.2
|
|
Proxy
Card for the Extraordinary General Meeting of Shareholders of the Company to be held on March 20, 2017
.
|
4
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Sep 2023 to Sep 2024